Estetrol – potential use in gynaecology and gynaecological oncology

Eliza Piechota; Włodzimierz Baranowski

eISSN: 2299-0038
ISSN: 1643-8876

Menopause Review/Przegląd Menopauzalny

Current issue Archive Manuscripts accepted About the journal Special Issues Editorial board Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures

Editorial System

Submit your Manuscript

Editorial Policies

Sarajevo Declaration on Integrity and Visibility of Scholarly Publications

Open access

2/2009
vol. 8

Send email

Copy url:

abstract:

Review paper

Estetrol – potential use in gynaecology and gynaecological oncology

Eliza Piechota

,

Włodzimierz Baranowski

Przegląd Menopauzalny 2009; 2: 84-86

Online publish date: 2009/05/11

View full text Get citation

Estetrol is a steroid produced by fetal liver. It was discovered over 40 years ago. At that time it was examined as a marker of high-risk pregnancy. The research was terminated as estetrol proved to be of limited use in this setting. In recent years interest in estetrol has renewed as it was shown to have qualities similar to SERM. In pre-clinical and phase II clinical trials it has been evaluated in alleviating the symptoms of menopause, prophylaxis of osteoporosis, prophylaxis and treatment of breast cancer and as an E component of combined oral contraceptives. Despite promising results further investigation is necessary to fully assess the clinical role of estetrol.

keywords:

Estetrol – potential use in gynaecology and gynaecological oncology

Eliza Piechota , Włodzimierz Baranowski

estetrol, menopause, osteoporosis, breast cancer, contraception

Eliza Piechota

,

Włodzimierz Baranowski